Meeting News

HemOnc Today honors Next Gen Innovators at ASCO

HemOnc Today unveiled its second class of Next Gen Innovators during ASCO Annual Meeting.

The publication’s 71 Next Gen Innovators — which include clinicians and researchers who specialize in solid tumors, hematologic malignancies and benign hematology — are a highly select group of early career hematologists and oncologists who have advanced their field through innovative approaches in the clinical and research settings.

HemOnc Today Editorial Board Members, along with other leaders in the field, nominated exceptional individuals for this honor.

 Pauline Funchain, MD, chats with Mark Leiser, editorial director for HemOnc Today.
Pauline Funchain, MD, chats with Mark Leiser, editorial director for HemOnc Today.
 Amy Comander, MD, and Sara Tolaney, MD, MPH, joined their fellow Next Gen Innovators at a reception on June 3 in Chicago.
Amy Comander, MD, and Sara Tolaney, MD, MPH, joined their fellow Next Gen Innovators at a reception on June 3 in Chicago.
 Foluso O. “Bisi” Ademuyiwa, MD, MPH, MSCI; Lindsay L. Peterson, MD, MSCR; and Jeffrey P. Ward, MD, PhD, all of Washington University School of Medicine in St. Louis, catch up during the reception.
Foluso O. “Bisi” Ademuyiwa, MD, MPH, MSCI; Lindsay L. Peterson, MD, MSCR; and Jeffrey P. Ward, MD, PhD, all of Washington University School of Medicine in St. Louis, catch up during the reception.
 Efrat Dotan, MD; Daneng Li, MD; and Richard J. Lee, MD, PhD, joined the celebration.
Efrat Dotan, MD; Daneng Li, MD; and Richard J. Lee, MD, PhD, joined the celebration.
 Davendra P.S. Sohal, MD, MPH, speaks with fellow honoree Vivek Narayan, MD, MSCE.
Davendra P.S. Sohal, MD, MPH, speaks with fellow honoree Vivek Narayan, MD, MSCE.
 Derek Raghavan, MD, PhD (center), HemOnc Today’s Chief Medical Editor for oncology, congratulates Mohamed E. Salem, MD (left), and Yanis Boumber, MD, PhD, on their selection as Next Gen Innovators.
Derek Raghavan, MD, PhD (center), HemOnc Today’s Chief Medical Editor for oncology, congratulates Mohamed E. Salem, MD (left), and Yanis Boumber, MD, PhD, on their selection as Next Gen Innovators.
 Van Morris, MD, MS, poses in front of a sign with the names of all HemOnc Today Next Gen Innovators. The sign was displayed at HemOnc Today’s booth in the exhibit hall at ASCO Annual Meeting.
Van Morris, MD, MS, poses in front of a sign with the names of all HemOnc Today Next Gen Innovators. The sign was displayed at HemOnc Today’s booth in the exhibit hall at ASCO Annual Meeting.

The Next Gen Innovators initiative — launched in December 2017 — will help showcase the talents and expertise of these rising stars in hematology and oncology by giving them a voice in HemOnc Today’s coverage.

Honorees will provide perspective on studies presented at major scientific meetings or published in peer-reviewed literature. They also will serve as sources for staff-written news articles, giving them an opportunity to share their views about research advances in their field and the challenges they face in their specialty.

“We would like to congratulate the members of the Next Gen Innovators and thank them for all of their individual accomplishments and contributions to the specialty,” said Joan-Marie Stiglich, ELS, Chief Content Officer of SLACK Incorporated, the publisher of HemOnc Today. “We look forward to working with this unique group of early career hematologists and oncologists to help bring a broader scope and perspective to our readers. It’s another step in our ongoing commitment to the entire hematology and oncology community.”

Here is a list of all HemOnc Today Next Gen Innovators:

Allistair Abraham, MD
Children’s National Health System
George Washington University

Foluso O. “Bisi” Ademuyiwa, MD, MPH, MSCI
Washington University School of Medicine in St. Louis

Rahul Aggarwal, MD
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Ibrahim T. Aldoss, MD
City of Hope

Mara B. Antonoff, MD, FACS
The University of Texas MD Anderson Cancer Center

Andrea B. Apolo, MD
National Cancer Institute

Matthew J. Barth, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo

Afsaneh Barzi, MD, PhD
Keck School of Medicine of USC
USC Norris Comprehensive Cancer Center

Aarti Bhatia, MD, MPH
Yale Cancer Center

Giada Bianchi, MD
Dana-Farber Cancer Institute

Kim A. Reiss Binder, MD
University of Pennsylvania

Yanis Boumber, MD, PhD
Fox Chase Cancer Center

Andrew M. Brunner, MD
Massachusetts General Hospital
Harvard Medical School

Huynh Cao, MD
Loma Linda University Health

George Chen, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo

Amy Comander, MD
Auerbach Breast Center
Newton-Wellesley Hospital
Massachusetts General Hospital Cancer Center
Harvard Medical School

Adam C. Cuker, MD, MS
University of Pennsylvania

Siddhartha Devarakonda, MD
Washington University School of Medicine in St. Louis

Efrat Dotan, MD
Fox Chase Cancer Center

Narjust Duma, MD    
Mayo Clinic
Rochester, Minn.

Andrew Dunbar, MD
Memorial Sloan Kettering Cancer Center

Areej El-Jawahri, MD
Massachusetts General Hospital
Harvard Medical School

Pauline Funchain, MD
Cleveland Clinic Taussig Cancer Institute

Ignacio Garrido-Laguna, MD, PhD
Huntsman Cancer Institute
The University of Utah

Lindsey A. George, MD
University of Pennsylvania
Children’s Hospital of Philadelphia

Aaron T. Gerds, MD, MS
Cleveland Clinic Taussig Cancer Institute

Damian J. Green, MD
University of Washington
Fred Hutchinson Cancer Research Center

Nicole R. Grieselhuber, MD, PhD
The Ohio State University

Elizabeth A. Griffiths, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo

Michael R. Grunwald, MD
Levine Cancer Institute
Atrium Health

Diana Hanna, MD
Keck School of Medicine of USC
USC Norris Comprehensive Cancer Center

Gabriela S. Hobbs, MD
Massachusetts General Hospital

Laura E. Hogan, MD
Stony Brook University

Kunal C. Kadakia, MD, FACP
Levine Cancer Institute
Atrium Health
The University of North Carolina at Chapel Hill

Julie Kanter, MD
Medical University of South Carolina

Kedar Kirtane, MD
University of Washington
Fred Hutchinson Cancer Research Center

Christopher A. Klebanoff, MD
Parker Institute for Cancer Immunotherapy
Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine

Dan Landau, MD, PhD
Weill Cornell Medicine
New York Genome Center

Richard J. Lee, MD, PhD
Massachusetts General Hospital
Harvard Medical School

Jose Pablo Leone, MD
Dana-Farber Cancer Institute

Daneng Li, MD
City of Hope

Gabriel Mannis, MD
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Benjamin Maughan, MD, PharmD
Huntsman Cancer Institute
The University of Utah

Van Morris, MD, MS
The University of Texas MD Anderson Cancer Center

Rakhi P. Naik, MD, MHS
Johns Hopkins Medicine

Vivek Narayan, MD, MSCE
University of Pennsylvania

Aziz Nazha, MD
Cleveland Clinic Taussig Cancer Institute

Ryan Nipp, MD, MPH
Massachusetts General Hospital
Harvard Medical School

Ifeyinwa Osunkwo, MD, MPH
Levine Cancer Institute
Atrium Health
The University of North Carolina at Chapel Hill

Taofeek Owonikoko, MD, PhD, MSCR
Winship Cancer Institute
Emory University

Steven Park, MD
Levine Cancer Institute
Atrium Health
The University of North Carolina at Chapel Hill

Sapna Pradyuman Patel, MD
The University of Texas MD Anderson Cancer Center

Lindsay L. Peterson, MD, MSCR
Washington University School of Medicine in St. Louis

Zofia Piotrowska, MD, MHS
Massachusetts General Hospital Cancer Center

Vinay K. Prasad, MD, MPH
Oregon Health & Science University

Pedram Razavi, MD, PhD
Memorial Sloan Kettering Cancer Center

Mohamed E. Salem, MD
Levine Cancer Institute
Atrium Health

Mina S. Sedrak, MD, MS
City of Hope

Deva Sharma, MD, MS
Vanderbilt University

Nicholas Short, MD
The University of Texas MD Anderson Cancer Center

Surbhi Sidana, MD
Mayo Clinic
Rochester, Minn.

Eric L. Smith, MD, PhD
Memorial Sloan Kettering Cancer Center

Davendra P.S. Sohal, MD, MPH
Cleveland Clinic Taussig Cancer Institute

Deborah M. Stephens, DO
Huntsman Cancer Institute
The University of Utah

Carlyn Tan, MD
Fox Chase Cancer Center

Sara Tolaney, MD, MPH
Harvard Medical School
Dana-Farber Cancer Institute

Pallawi Torka, MD
Roswell Park Comprehensive Cancer Center

Katy K. Tsai, MD
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Eduardo Vilar-Sanchez, MD, PhD
The University of Texas MD Anderson Cancer Center

Jeffrey P. Ward, MD, PhD
Washington University School of Medicine in St. Louis

Jason C. Ye, MD
Keck School of Medicine of USC
USC Norris Comprehensive Cancer Center

Nominations may be sent to Editorial Director Mark Leiser at mleiser@healio.com.

HemOnc Today unveiled its second class of Next Gen Innovators during ASCO Annual Meeting.

The publication’s 71 Next Gen Innovators — which include clinicians and researchers who specialize in solid tumors, hematologic malignancies and benign hematology — are a highly select group of early career hematologists and oncologists who have advanced their field through innovative approaches in the clinical and research settings.

HemOnc Today Editorial Board Members, along with other leaders in the field, nominated exceptional individuals for this honor.

 Pauline Funchain, MD, chats with Mark Leiser, editorial director for HemOnc Today.
Pauline Funchain, MD, chats with Mark Leiser, editorial director for HemOnc Today.
 Amy Comander, MD, and Sara Tolaney, MD, MPH, joined their fellow Next Gen Innovators at a reception on June 3 in Chicago.
Amy Comander, MD, and Sara Tolaney, MD, MPH, joined their fellow Next Gen Innovators at a reception on June 3 in Chicago.
 Foluso O. “Bisi” Ademuyiwa, MD, MPH, MSCI; Lindsay L. Peterson, MD, MSCR; and Jeffrey P. Ward, MD, PhD, all of Washington University School of Medicine in St. Louis, catch up during the reception.
Foluso O. “Bisi” Ademuyiwa, MD, MPH, MSCI; Lindsay L. Peterson, MD, MSCR; and Jeffrey P. Ward, MD, PhD, all of Washington University School of Medicine in St. Louis, catch up during the reception.
 Efrat Dotan, MD; Daneng Li, MD; and Richard J. Lee, MD, PhD, joined the celebration.
Efrat Dotan, MD; Daneng Li, MD; and Richard J. Lee, MD, PhD, joined the celebration.
 Davendra P.S. Sohal, MD, MPH, speaks with fellow honoree Vivek Narayan, MD, MSCE.
Davendra P.S. Sohal, MD, MPH, speaks with fellow honoree Vivek Narayan, MD, MSCE.
 Derek Raghavan, MD, PhD (center), HemOnc Today’s Chief Medical Editor for oncology, congratulates Mohamed E. Salem, MD (left), and Yanis Boumber, MD, PhD, on their selection as Next Gen Innovators.
Derek Raghavan, MD, PhD (center), HemOnc Today’s Chief Medical Editor for oncology, congratulates Mohamed E. Salem, MD (left), and Yanis Boumber, MD, PhD, on their selection as Next Gen Innovators.
 Van Morris, MD, MS, poses in front of a sign with the names of all HemOnc Today Next Gen Innovators. The sign was displayed at HemOnc Today’s booth in the exhibit hall at ASCO Annual Meeting.
Van Morris, MD, MS, poses in front of a sign with the names of all HemOnc Today Next Gen Innovators. The sign was displayed at HemOnc Today’s booth in the exhibit hall at ASCO Annual Meeting.

The Next Gen Innovators initiative — launched in December 2017 — will help showcase the talents and expertise of these rising stars in hematology and oncology by giving them a voice in HemOnc Today’s coverage.

Honorees will provide perspective on studies presented at major scientific meetings or published in peer-reviewed literature. They also will serve as sources for staff-written news articles, giving them an opportunity to share their views about research advances in their field and the challenges they face in their specialty.

“We would like to congratulate the members of the Next Gen Innovators and thank them for all of their individual accomplishments and contributions to the specialty,” said Joan-Marie Stiglich, ELS, Chief Content Officer of SLACK Incorporated, the publisher of HemOnc Today. “We look forward to working with this unique group of early career hematologists and oncologists to help bring a broader scope and perspective to our readers. It’s another step in our ongoing commitment to the entire hematology and oncology community.”

Here is a list of all HemOnc Today Next Gen Innovators:

Allistair Abraham, MD
Children’s National Health System
George Washington University

Foluso O. “Bisi” Ademuyiwa, MD, MPH, MSCI
Washington University School of Medicine in St. Louis

Rahul Aggarwal, MD
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Ibrahim T. Aldoss, MD
City of Hope

Mara B. Antonoff, MD, FACS
The University of Texas MD Anderson Cancer Center

Andrea B. Apolo, MD
National Cancer Institute

Matthew J. Barth, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo

Afsaneh Barzi, MD, PhD
Keck School of Medicine of USC
USC Norris Comprehensive Cancer Center

Aarti Bhatia, MD, MPH
Yale Cancer Center

Giada Bianchi, MD
Dana-Farber Cancer Institute

Kim A. Reiss Binder, MD
University of Pennsylvania

Yanis Boumber, MD, PhD
Fox Chase Cancer Center

Andrew M. Brunner, MD
Massachusetts General Hospital
Harvard Medical School

Huynh Cao, MD
Loma Linda University Health

George Chen, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo

Amy Comander, MD
Auerbach Breast Center
Newton-Wellesley Hospital
Massachusetts General Hospital Cancer Center
Harvard Medical School

Adam C. Cuker, MD, MS
University of Pennsylvania

Siddhartha Devarakonda, MD
Washington University School of Medicine in St. Louis

Efrat Dotan, MD
Fox Chase Cancer Center

Narjust Duma, MD    
Mayo Clinic
Rochester, Minn.

Andrew Dunbar, MD
Memorial Sloan Kettering Cancer Center

Areej El-Jawahri, MD
Massachusetts General Hospital
Harvard Medical School

Pauline Funchain, MD
Cleveland Clinic Taussig Cancer Institute

Ignacio Garrido-Laguna, MD, PhD
Huntsman Cancer Institute
The University of Utah

Lindsey A. George, MD
University of Pennsylvania
Children’s Hospital of Philadelphia

Aaron T. Gerds, MD, MS
Cleveland Clinic Taussig Cancer Institute

Damian J. Green, MD
University of Washington
Fred Hutchinson Cancer Research Center

Nicole R. Grieselhuber, MD, PhD
The Ohio State University

Elizabeth A. Griffiths, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo

Michael R. Grunwald, MD
Levine Cancer Institute
Atrium Health

Diana Hanna, MD
Keck School of Medicine of USC
USC Norris Comprehensive Cancer Center

Gabriela S. Hobbs, MD
Massachusetts General Hospital

Laura E. Hogan, MD
Stony Brook University

Kunal C. Kadakia, MD, FACP
Levine Cancer Institute
Atrium Health
The University of North Carolina at Chapel Hill

Julie Kanter, MD
Medical University of South Carolina

Kedar Kirtane, MD
University of Washington
Fred Hutchinson Cancer Research Center

Christopher A. Klebanoff, MD
Parker Institute for Cancer Immunotherapy
Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine

Dan Landau, MD, PhD
Weill Cornell Medicine
New York Genome Center

Richard J. Lee, MD, PhD
Massachusetts General Hospital
Harvard Medical School

Jose Pablo Leone, MD
Dana-Farber Cancer Institute

Daneng Li, MD
City of Hope

Gabriel Mannis, MD
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Benjamin Maughan, MD, PharmD
Huntsman Cancer Institute
The University of Utah

Van Morris, MD, MS
The University of Texas MD Anderson Cancer Center

Rakhi P. Naik, MD, MHS
Johns Hopkins Medicine

Vivek Narayan, MD, MSCE
University of Pennsylvania

Aziz Nazha, MD
Cleveland Clinic Taussig Cancer Institute

Ryan Nipp, MD, MPH
Massachusetts General Hospital
Harvard Medical School

Ifeyinwa Osunkwo, MD, MPH
Levine Cancer Institute
Atrium Health
The University of North Carolina at Chapel Hill

Taofeek Owonikoko, MD, PhD, MSCR
Winship Cancer Institute
Emory University

Steven Park, MD
Levine Cancer Institute
Atrium Health
The University of North Carolina at Chapel Hill

Sapna Pradyuman Patel, MD
The University of Texas MD Anderson Cancer Center

Lindsay L. Peterson, MD, MSCR
Washington University School of Medicine in St. Louis

Zofia Piotrowska, MD, MHS
Massachusetts General Hospital Cancer Center

Vinay K. Prasad, MD, MPH
Oregon Health & Science University

Pedram Razavi, MD, PhD
Memorial Sloan Kettering Cancer Center

Mohamed E. Salem, MD
Levine Cancer Institute
Atrium Health

Mina S. Sedrak, MD, MS
City of Hope

Deva Sharma, MD, MS
Vanderbilt University

Nicholas Short, MD
The University of Texas MD Anderson Cancer Center

Surbhi Sidana, MD
Mayo Clinic
Rochester, Minn.

Eric L. Smith, MD, PhD
Memorial Sloan Kettering Cancer Center

Davendra P.S. Sohal, MD, MPH
Cleveland Clinic Taussig Cancer Institute

Deborah M. Stephens, DO
Huntsman Cancer Institute
The University of Utah

Carlyn Tan, MD
Fox Chase Cancer Center

Sara Tolaney, MD, MPH
Harvard Medical School
Dana-Farber Cancer Institute

Pallawi Torka, MD
Roswell Park Comprehensive Cancer Center

Katy K. Tsai, MD
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Eduardo Vilar-Sanchez, MD, PhD
The University of Texas MD Anderson Cancer Center

Jeffrey P. Ward, MD, PhD
Washington University School of Medicine in St. Louis

Jason C. Ye, MD
Keck School of Medicine of USC
USC Norris Comprehensive Cancer Center

Nominations may be sent to Editorial Director Mark Leiser at mleiser@healio.com.